Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Libenzapril (CGS 16617) is a potent angiotensin-converting enzyme inhibitor used to study myocardial injury.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | 在庫あり | ¥ 57,500 |
5 mg | 在庫あり | ¥ 143,000 |
10 mg | 在庫あり | ¥ 203,500 |
25 mg | 在庫あり | ¥ 305,500 |
50 mg | 在庫あり | ¥ 408,500 |
100 mg | 在庫あり | ¥ 558,000 |
説明 | Libenzapril (CGS 16617) is a potent angiotensin-converting enzyme inhibitor used to study myocardial injury. |
別名 | CGS 16617, Abutapril |
分子量 | 363.41 |
分子式 | C18H25N3O5 |
CAS No. | 109214-55-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: < 1mg/ml (insoluble)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Libenzapril 109214-55-3 Metabolism Angiotensin-converting Enzyme (ACE) CGS-16617 CGS 16617 CGS16617 Abutapril Inhibitor inhibitor inhibit